Here are some of the best-performing, actively managed choices with low expense ratios.
Amgen, Celgene and Pharmacyclics see short interest drop recently.
There's mixed interest in biotech, biopharmaceutical and emerging pharma companies.
Look to these investments this week for strength as stocks continue to outperform.
This biotech behemoth's appeal is its combined value-and-growth stock characteristics.
Remember when I said you want to buy a pullback? Take a good, long look at these stellar names.
The month also features a big gathering of biotech CEOs in New York and a cancer research meeting in Florida.
VIDEO ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
A new survey reveals Americans are most embarrassed to admit their amount of credit card debt.
In a tax case, a US judge ruled that the agency's published guidelines don't hold up in court.
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'